Calixa Therapeutics - Ownership and Business Overview

Life ScienceCompany

Calixa Therapeutics Ownership

Who owns Calixa Therapeutics?

Calixa Therapeutics is owned by Cubist Pharmaceuticals. It was acquired on December 14, 2009.

Calixa Therapeutics Business Overview

Where is Calixa Therapeutics headquartered?

Calixa Therapeutics is headquartered in San Diego, California.

What sector is Calixa Therapeutics in?

Calixa Therapeutics is a life science company.

When was Calixa Therapeutics founded?

Calixa Therapeutics was founded in 2007.

Life Science M&A Summary in 2009

Out of 60 sectors in the Mergr database, life science ranked 6 in number of deals in 2009. The largest life science acquisition in 2009 was Wyeth - which was acquired by Pfizer for $68.0B.

Subscribe to Mergr to view all 111 acquisitions of life science companies in 2009, including 13 acquisitions by private equity firms, and 98 by strategics.

Calixa Therapeutics, Inc.

12481 High Bluff Drive, Suite 150,
San Diego, California 92130
United States,
(858) 480-2420
www.calixainc.com

Calixa Therapeutics, Inc. is a biopharmaceutical company focused on the development of novel antibiotics that address the expanding problem of multi-drug resistant Gram-negative pathogens.


 Subscribe to unlock this and 215,016
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore a company's M&A activity, ownership history, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 208K M&A Transactions
  • 210K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

What next?

Get Full Access

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for Calixa Therapeutics

Life Science Companies